AI assistant
Linde PLC — Director's Dealing 2025
May 20, 2025
9953_dirs_2025-05-20_9ef92341-0a59-457c-b584-950b6c313ce3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LINDE PLC (LIN)
CIK: 0001707925
Period of Report: 2025-05-16
Reporting Person: Strauss David P (Executive VP, Chief HR Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-16 | Ordinary Shares | S | 1987.16 | $457.04 | Disposed | 22639.04 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 4688.993 | Direct |
| Ordinary Shares | 1949.383 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $0 | Ordinary Shares (1278) | 1278 | Direct | |
| Restricted Stock Units | $ | Ordinary Shares (1235) | 1235 | Direct | |
| Restricted Stock Units | $ | Ordinary Shares (1290) | 1290 | Direct | |
| Stock Options (right to buy) | $468.77 | 2035-03-07 | Ordinary Shares (8973) | 8973 | Direct |
| Stock Options (right to buy) | $465.29 | 2034-03-07 | Ordinary Shares (8010) | 8010 | Direct |
| Stock Options (right to buy) | $354.14 | 2033-03-07 | Ordinary Shares (8515) | 8515 | Direct |
| Stock Options (right to buy) | $270.99 | 2032-03-07 | Ordinary Shares (10200) | 10200 | Direct |
| Stock Options (right to buy) | $253.68 | 2031-03-08 | Ordinary Shares (15925) | 15925 | Direct |
| Stock Options (right to buy) | $173.13 | 2030-03-09 | Ordinary Shares (20870) | 20870 | Direct |
| Stock Options (right to buy) | $176.63 | 2029-03-20 | Ordinary Shares (20985) | 20985 | Direct |
| Stock Options (right to buy) | $154 | 2028-02-27 | Ordinary Shares (7545) | 7545 | Direct |
| Deferred Stock Units | $ | Ordinary Shares (276.362) | 276.362 | Direct |
Footnotes
F1: The price reported is the weighted average sale price per share. The sale prices ranged from $456.94 to $457.14 per share. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
F2: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
F3: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
F5: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
F6: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
F9: This option vested in full over three years beginning on March 8, 2022.
F10: This option vested in full over three years beginning on March 9, 2021.
F11: This option vested in full over three years beginning March 20, 2020.
F12: This option vested in full over three years beginning on February 27, 2019.
F13: Conversion to Linde plc Ordinary Shares is on a one-to-one basis.
F14: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.